name:-0.15607714653015
name:-0.1247980594635
name:-0.075509071350098
Sunovion Pharmaceuticals Inc. Patent Filings

Sunovion Pharmaceuticals Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sunovion Pharmaceuticals Inc..The latest application filed is for "child-resistant dispensers for thin strip medications".

Company Profile
105.200.200
  • Sunovion Pharmaceuticals Inc. - Marlborough MA US
  • Sunovion Pharmaceuticals Inc. - Paramus NJ
  • SUNOVION PHARMACEUTICALS INC. -
  • Sunovion Pharmaceuticals Inc. - Malborough MA US
  • SUNOVION PHARMACEUTICALS INC. - Marborough MA US
  • SUNOVION PHARMACEUTICALS INC - Marlborough MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Salts, crystal forms, and production methods thereof
Grant 11,440,921 - Bauer , et al. September 13, 2
2022-09-13
Sublingual films
Grant 11,419,769 - Bryson , et al. August 23, 2
2022-08-23
Nebulizer monitoring device, system and method
Grant 11,406,786 - Segal , et al. August 9, 2
2022-08-09
Child-resistant Dispensers For Thin Strip Medications
App 20220241156 - BILBAULT; Thierry ;   et al.
2022-08-04
Crystal forms and production methods thereof
Grant 11,370,753 - Snoonian , et al. June 28, 2
2022-06-28
1-heterocyclyl Isochromanyl Compounds And Analogs For Treating Cns Disorders
App 20220185799 - XIE; Linghong ;   et al.
2022-06-16
Child Resistant Peel Pouch
App 20220161983 - CARDIN; Julie A. ;   et al.
2022-05-26
Heteroaryl compounds and methods of use thereof
Grant 11,332,462 - Campbell , et al. May 17, 2
2022-05-17
Easy-open peel pouch
Grant 11,312,554 - Cardin , et al. April 26, 2
2022-04-26
Modified Release Formulations And Uses Thereof
App 20220117899 - Asada; Takumi ;   et al.
2022-04-21
Salts Of A Heterocyclic Compound And Crystalline Forms, Processes For Preparing, Therapeutic Uses, And Pharmaceutical Compositions Thereof
App 20220098163 - BHOGLE; Nandkumar Nivritti ;   et al.
2022-03-31
Methods Of Treating Schizophrenia
App 20220062229 - Hopkins; Seth ;   et al.
2022-03-03
Methods Of Treating Central Nervous System Disorders
App 20210386689 - LIN; Jing
2021-12-16
1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders
Grant 11,192,885 - Xie , et al. December 7, 2
2021-12-07
Dual NAV1.2/5HT2a inhibitors for treating CNS disorders
Grant 11,186,564 - Heffernan , et al. November 30, 2
2021-11-30
Modified release formulations and uses thereof
Grant 11,160,758 - Asada , et al. November 2, 2
2021-11-02
Sublingual Apomorphine
App 20210322403 - GIOVINAZZO; Anthony John ;   et al.
2021-10-21
Methods Of Treating Neurological And Psychiatric Disorders
App 20210315859 - BOWEN; Carrie A. ;   et al.
2021-10-14
Methods Of Treating A Patient Having Parkinson's Disease
App 20210315882 - BILBAULT; Thierry ;   et al.
2021-10-14
Nonracemic Mixtures And Uses Thereof
App 20210315860 - Hopkins; Seth Cabot ;   et al.
2021-10-14
Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
Grant 11,136,304 - Bhogle , et al. October 5, 2
2021-10-05
Fused Dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl Compounds And Analogs For Treating Cns Disorders
App 20210300942 - CHYTIL; Milan ;   et al.
2021-09-30
Methods of treating schizophrenia
Grant 11,129,807 - Hopkins , et al. September 28, 2
2021-09-28
Multicyclic Compounds And Methods Of Use Thereof
App 20210267938 - SHAO; Liming ;   et al.
2021-09-02
Compounds and compositions and uses thereof
Grant 11,077,090 - Alexandrov , et al. August 3, 2
2021-08-03
Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
Grant 11,066,380 - Bhogle , et al. July 20, 2
2021-07-20
Methods Of Treating Parkinson's Disease By Administration Of Apomorphine To An Oral Mucosa
App 20210205208 - BARNHART; Scott David ;   et al.
2021-07-08
Acid Addition Salts Of Apomorphine, Pharmaceutical Compositions Containing The Same, And Methods Of Using The Same
App 20210179561 - BILBAULT; Thierry
2021-06-17
Compounds And Uses Thereof
App 20210093606 - Bowen; Carrie A. ;   et al.
2021-04-01
Methods of treating Parkinson's disease by administration of apomorphine to an oral mucosa
Grant 10,959,943 - Barnhart , et al. March 30, 2
2021-03-30
Crystal Forms And Production Methods Thereof
App 20210061759 - Snoonian; John R. ;   et al.
2021-03-04
Salts, Crystal Forms, And Production Methods Thereof
App 20210053983 - BAUER; Andrea ;   et al.
2021-02-25
Compounds and compositions and uses thereof
Grant 10,927,124 - Xie , et al. February 23, 2
2021-02-23
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE
App 20210046021 - JERUSSI; Thomas ;   et al.
2021-02-18
Multicyclic compounds and methods of use thereof
Grant 10,894,033 - Shao , et al. January 19, 2
2021-01-19
Methods Of Treating Social Function Disorders
App 20210008030 - BLUM; David
2021-01-14
Easy-open Peel Pouch
App 20210002051 - CARDIN; Julie A. ;   et al.
2021-01-07
Oral Dosage Forms
App 20200405867 - ONITA; Maiko ;   et al.
2020-12-31
Nonracemic mixtures and uses thereof
Grant 10,874,639 - Hopkins , et al. December 29, 2
2020-12-29
Modified Release Formulations And Uses Thereof
App 20200383924 - Asada; Takumi ;   et al.
2020-12-10
Easy-open peel pouch
Grant 10,815,042 - Cardin , et al. October 27, 2
2020-10-27
Salts, crystal forms, and production methods thereof
Grant 10,815,249 - Bauer , et al. October 27, 2
2020-10-27
Nebulizer Monitoring Device, System And Method
App 20200330719 - SEGAL; Michael ;   et al.
2020-10-22
Multicyclic Compounds And Methods Of Use Thereof
App 20200323819 - SHAO; Liming ;   et al.
2020-10-15
Crystal forms and production methods thereof
Grant 10,800,738 - Snoonian , et al. October 13, 2
2020-10-13
Compounds and uses thereof
Grant 10,780,074 - Bowen , et al. Sept
2020-09-22
Salts Of A Heterocyclic Compound And Crystalline Forms, Processes For Preparing, Therapeutic Uses, And Pharmaceutical Compositions Thereof
App 20200290987 - BHOGLE; Nandkumar Nivritti ;   et al.
2020-09-17
Heteroaryl Compounds And Methods Of Use Thereof
App 20200277286 - CAMPBELL; John Emmerson ;   et al.
2020-09-03
Nonracemic Mixtures And Uses Thereof
App 20200237719 - Hopkins; Seth Cabot ;   et al.
2020-07-30
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
Grant 10,702,486 - Jerussi , et al.
2020-07-07
Methods Of Treating Neurological And Psychiatric Disorders
App 20200179336 - HOPKINS; Seth Cabot
2020-06-11
Crystal Forms And Production Methods Thereof
App 20200165200 - Snoonian; John R. ;   et al.
2020-05-28
Nonracemic mixtures and uses thereof
Grant 10,660,875 - Hopkins , et al.
2020-05-26
Nonracemic Mixtures And Uses Thereof
App 20200147040 - Hopkins; Seth Cabot ;   et al.
2020-05-14
Metabotrophic glutamate receptor 5 modulators and methods use thereof
Grant 10,640,510 - Heffernan , et al.
2020-05-05
Methods Of Treating Schizophrenia
App 20200129477 - HOPKINS; Seth ;   et al.
2020-04-30
Metabotrophic Glutamate Receptor 5 Modulators And Methods Use Thereof
App 20200079778 - Heffernan; Michele L.R. ;   et al.
2020-03-12
Methods Of Treating Parkinson's Disease By Administration Of Apomorphine To An Oral Mucosa
App 20200069571 - BARNHART; Scott David ;   et al.
2020-03-05
Crystal forms and production methods thereof
Grant 10,577,317 - Snoonian , et al.
2020-03-03
Nonracemic mixtures and uses thereof
Grant 10,576,058 - Hopkins , et al.
2020-03-03
Substituted imidazo[1,2-a]pyridines as PDE-10 inhibitors
Grant 10,570,156 - Campbell , et al. Feb
2020-02-25
Cycloalkylamines as monoamine reuptake inhibitors
Grant 10,562,878 - Shao , et al. Feb
2020-02-18
Substituted quinoxalines as PDE-10 inhibitors
Grant 10,562,916 - Campbell , et al. Feb
2020-02-18
Heteroaryl compounds and methods of use thereof
Grant 10,556,890 - Campbell , et al. Feb
2020-02-11
Sublingual Apomorphine
App 20200030315 - GIOVINAZZO; Anthony John ;   et al.
2020-01-30
Fused Dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl Compounds And Analogs For Treating Cns Disorders
App 20200024286 - CHYTIL; Milan ;   et al.
2020-01-23
Metabotrophic glutamate receptor 5 modulators and methods of use thereof
Grant 10,533,000 - Heffernan , et al. Ja
2020-01-14
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE
App 20200000746 - JERUSSI; Thomas ;   et al.
2020-01-02
1-heterocyclyl Isochromanyl Compounds And Analogs For Treating Cns Disorders
App 20190389845 - Xie; Linghong ;   et al.
2019-12-26
Salts Of A Heterocyclic Compound And Crystalline Forms, Processes For Preparing, Therapeutic Uses, And Pharmaceutical Compositio
App 20190375764 - BHOGLE; Nandkumar Nivritti ;   et al.
2019-12-12
Sublingual Films
App 20190365661 - BRYSON; Nathan John ;   et al.
2019-12-05
Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
Grant 10,449,146 - Barnhart , et al. Oc
2019-10-22
Crystal Forms And Production Methods Thereof
App 20190315686 - Snoonian; John R. ;   et al.
2019-10-17
Nonracemic Mixtures And Uses Thereof
App 20190314331 - Hopkins; Seth Cabot ;   et al.
2019-10-17
Compounds And Compositions And Uses Thereof
App 20190308990 - Xie; Linghong ;   et al.
2019-10-10
Enamide process
Grant 10,435,351 - Vandenbossche , et al. O
2019-10-08
Triple reuptake inhibitors and methods of their use
Grant 10,428,021 - Shao , et al. October 1, 2
2019-10-01
Sublingual apomorphine
Grant 10,420,763 - Giovinazzo , et al. Sept
2019-09-24
Salts, Crystal Forms, And Production Methods Thereof
App 20190256525 - Bauer; Andrea ;   et al.
2019-08-22
Crystal forms and production methods thereof
Grant 10,377,708 - Snoonian , et al. A
2019-08-13
Nonracemic mixtures and uses thereof
Grant 10,369,134 - Hopkins , et al.
2019-08-06
1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders
Grant 10,336,732 - Xie , et al.
2019-07-02
DUAL NAV1.2/5HT2a INHIBITORS FOR TREATING CNS DISORDERS
App 20190194163 - HEFFERNAN; Michele L.R. ;   et al.
2019-06-27
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
Grant 10,328,036 - Jerussi , et al.
2019-06-25
Crystal Forms And Production Methods Thereof
App 20190169123 - Snoonian; John R. ;   et al.
2019-06-06
Nonracemic Mixtures And Uses Thereof
App 20190167635 - Hopkins; Seth Cabot ;   et al.
2019-06-06
Sublingual films
Grant 10,285,953 - Bryson , et al.
2019-05-14
Metabotrophic Glutamate Receptor 5 Modulators And Methods Use Thereof
App 20190135815 - Heffernan; Michele L.R. ;   et al.
2019-05-09
Multicyclic Compounds And Methods Of Use Thereof
App 20190125722 - SHAO; Liming ;   et al.
2019-05-02
Compounds For Treating Disorders Mediated By Metabotropic Glutamate Receptor 5, And Methods Of Use Thereof
App 20190055204 - Hardy; Larry Wendell ;   et al.
2019-02-21
Compounds And Uses Thereof
App 20190038594 - Bowen; Carrie A. ;   et al.
2019-02-07
Metabotrophic glutamate receptor 5 modulators and methods use thereof
Grant 10,196,399 - Heffernan , et al. Fe
2019-02-05
Compounds and compositions and uses thereof
Grant 10,196,403 - Hanania , et al. Fe
2019-02-05
Heteroaryl Compounds And Methods Of Use Thereof
App 20190031685 - Jones; Philip G. ;   et al.
2019-01-31
Heteroaryl compounds and methods of use thereof
Grant 10,189,825 - Campbell , et al. Ja
2019-01-29
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE
App 20180333373 - Jerussi; Thomas ;   et al.
2018-11-22
Sublingual Apomorphine
App 20180289699 - GIOVINAZZO; Anthony John ;   et al.
2018-10-11
Multicyclic compounds and methods of use thereof
Grant 10,085,968 - Shao , et al. October 2, 2
2018-10-02
Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
Grant 10,077,243 - Hardy , et al. September 18, 2
2018-09-18
Dosage of dasotraline and method for treatment of ADHD
Grant 10,076,503 - Loebel , et al. September 18, 2
2018-09-18
Cycloalkylamines As Monoamine Reuptake Inhibitors
App 20180230120 - SHAO; Liming ;   et al.
2018-08-16
Levalbuterol Salt
App 20180222845 - McGlynn; Paul ;   et al.
2018-08-09
Enamide Process
App 20180215702 - Vandenbossche; Charles ;   et al.
2018-08-02
Preparation of chiral amides and amines
Grant 10,011,559 - Zhao , et al. July 3, 2
2018-07-03
Substituted [1,2,4]triazolo[1,5-a]pyrazines as phosphodiesterase inhibitors
Grant 9,994,590 - Campbell , et al. June 12, 2
2018-06-12
Triple Reuptake Inhibitors And Methods Of Their Use
App 20180148407 - Shao; Liming ;   et al.
2018-05-31
Methods Of Treating Parkinson's Disease By Administration Of Apomorphine To An Oral Mucosa
App 20180133146 - BARNHART; Scott David ;   et al.
2018-05-17
Heteroaryl Compounds And Methods Of Use Thereof
App 20180118727 - CAMPBELL; John Emmerson ;   et al.
2018-05-03
D2 receptor modulators and methods of use thereof in the treatment of diseases and disorders
Grant 9,951,088 - Jones , et al. April 24, 2
2018-04-24
1-heterocyclyl Isochromanyl Compounds And Analogs For Treating Cns Disorders
App 20180093974 - Xie; Linghong ;   et al.
2018-04-05
Heteroaryl Compounds And Methods Of Use Thereof
App 20180072759 - Campbell; John Emmerson ;   et al.
2018-03-15
Formulations, Salts And Polymorphs Of Transnorsertraline And Uses Thereof
App 20180071230 - Laughlin; Sharon M. ;   et al.
2018-03-15
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
Grant 9,907,764 - Jerussi , et al. March 6, 2
2018-03-06
Fused Dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl Compounds And Analogs For Treating Cns Disorders
App 20180057506 - CHYTIL; Milan ;   et al.
2018-03-01
Metabotrophic Glutamate Receptor 5 Modulators And Methods Use Thereof
App 20180037585 - Heffernan; Michele L.R. ;   et al.
2018-02-08
Substituted Quinolines As Pde-10 Inhibitors
App 20180037590 - Campbell; John Emmerson ;   et al.
2018-02-08
Heterocyclic compounds and methods of use thereof
Grant 9,884,844 - Fang , et al. February 6, 2
2018-02-06
Compounds And Compositions And Uses Thereof
App 20180028492 - POWELL; Noel Aaron ;   et al.
2018-02-01
Compounds And Compositions And Uses Thereof
App 20180030064 - XIE; Linghong ;   et al.
2018-02-01
Preparation Of Chiral Amides And Amines
App 20180016224 - ZHAO; Hang ;   et al.
2018-01-18
Cycloalkylamines as monoamine reuptake inhibitors
Grant 9,868,718 - Shao , et al. January 16, 2
2018-01-16
1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders
Grant 9,856,238 - Xie , et al. January 2, 2
2018-01-02
Substituted pyrazolo[1,5-a]pyridines as PDE-10 inhibitors
Grant 9,856,274 - Campbell , et al. January 2, 2
2018-01-02
Triple reuptake inhibitors and methods of their use
Grant 9,850,204 - Shao , et al. December 26, 2
2017-12-26
Substituted quinolines as PDE-10 inhibitors
Grant 9,834,564 - Campbell , et al. December 5, 2
2017-12-05
Tricyclic Derivative
App 20170273985 - Burdi; Douglas F. ;   et al.
2017-09-28
Methods And Compositions Of Dasotraline For Treatment Of Adhd
App 20170266133 - LOEBEL; Antony D. ;   et al.
2017-09-21
Dosage Of Dasotraline And Method For Treatment Of Adhd
App 20170266134 - LOEBEL; Antony D. ;   et al.
2017-09-21
Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disorders
Grant 9,758,529 - Chytil , et al. September 12, 2
2017-09-12
Phenyl Substituted Cycloalkylamines As Monoamine Reputake Inhibitors
App 20170204050 - SHAO; Liming ;   et al.
2017-07-20
Metabotrophic glutamate receptor 5 modulators and methods of use thereof
Grant 9,708,331 - Heffernan , et al. July 18, 2
2017-07-18
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE
App 20170157067 - JERUSSI; Thomas ;   et al.
2017-06-08
Sublingual apomorphine
Grant 9,669,020 - Giovinazzo , et al. June 6, 2
2017-06-06
Heteroaryl compounds and methods of use thereof
Grant 9,670,230 - Campbell , et al. June 6, 2
2017-06-06
Sublingual apomorphine
Grant 9,669,019 - Giovinazzo , et al. June 6, 2
2017-06-06
Sublingual apomorphine
Grant 9,669,021 - Giovinazzo , et al. June 6, 2
2017-06-06
Sublingual apomorphine
Grant 9,669,018 - Giovinazzo , et al. June 6, 2
2017-06-06
Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
Grant 9,586,888 - Shao , et al. March 7, 2
2017-03-07
Modulators of opioid receptors and methods of use thereof
Grant 9,580,409 - Malcolm , et al. February 28, 2
2017-02-28
1-heterocyclyl Isochromanyl Compounds And Analogs For Treating Cns Disorders
App 20170001987 - Xie; Linghong ;   et al.
2017-01-05
Levalbuterol Salt
App 20160368858 - McGlynn; Paul ;   et al.
2016-12-22
Solid Forms Comprising(-)-O-Desmethylvenlafaxine And Uses Thereof
App 20160355457 - Sizensky; Michael ;   et al.
2016-12-08
Substituted [1,2,4]triazolo[1,5-a]pyrazines as phosphodiesterase inhibitors
Grant 9,505,751 - Campbell , et al. November 29, 2
2016-11-29
Pyrrolidine triple reuptake inhibitors
Grant 9,505,716 - Shao , et al. November 29, 2
2016-11-29
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
Grant 9,498,452 - Jerussi , et al. November 22, 2
2016-11-22
Acetamide stereoisomer
Grant 9,499,476 - Abolin , et al. November 22, 2
2016-11-22
Fused Dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl Compounds And Analogs For Treating Cns Disorders
App 20160264597 - Chytil; Milan ;   et al.
2016-09-15
Metabotrophic Glutamate Receptor 5 Modulators And Methods Of Use Thereof
App 20160251359 - Heffernan; Michele L.R. ;   et al.
2016-09-01
Triple Reuptake Inhibitors And Methods Of Their Use
App 20160221947 - Shao; Liming ;   et al.
2016-08-04
Multicyclic compounds and methods of use thereof
Grant 9,351,954 - Shao , et al. May 31, 2
2016-05-31
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE
App 20160136111 - Jerussi; Thomas ;   et al.
2016-05-19
Pyrrolidine Triple Reuptake Inhibitors
App 20160115123 - SHAO; Liming ;   et al.
2016-04-28
Heteroaryl Compounds And Methods Of Use Thereof
App 20160102106 - Campbell; John Emmerson ;   et al.
2016-04-14
Tricyclic Piperazine Derivative
App 20160083391 - Burdi; Douglas F. ;   et al.
2016-03-24
Multicyclic Compounds And Methods Of Use Thereof
App 20160083399 - SHAO; Liming ;   et al.
2016-03-24
Tricyclic Guanidine Derivative
App 20160083400 - Burdi; Douglas F. ;   et al.
2016-03-24
Metabotrophic glutamate receptor 5 modulators and methods of use thereof
Grant 9,260,452 - Heffernan , et al. February 16, 2
2016-02-16
Substituted [1,2,4]triazolo[1,5-a]pyridines as PDE-10 inhibitors
Grant 9,249,162 - Campbell , et al. February 2, 2
2016-02-02
Preparation Of Chiral Amides And Amines
App 20160016891 - ZHAO; Hang ;   et al.
2016-01-21
Heterocyclic Compounds And Methods Of Use Thereof
App 20150336928 - FANG; Qun Kevin ;   et al.
2015-11-26
Heteroaryl Compounds And Methods Of Use Thereof
App 20150322090 - Campbell; John Emmerson ;   et al.
2015-11-12
Derivatives Of (-)-venlafaxine And Methods Of Preparing And Using The Same
App 20150299102 - Jerussi; Thomas P. ;   et al.
2015-10-22
Heteroaryl Compounds And Methods Of Use Thereof
App 20150291626 - Campbell; John Emmerson ;   et al.
2015-10-15
Triple reuptake inhibitors and methods of their use
Grant 9,133,117 - Shao , et al. September 15, 2
2015-09-15
Coated tablets of eszopiclone
Grant 9,114,086 - Hsia , et al. August 25, 2
2015-08-25
Acetamide Stereoisomer
App 20150225334 - ABOLIN; Craig R. ;   et al.
2015-08-13
(r,r) Formoterol In Combination With Other Pharmacological Agents
App 20150209311 - Barberich; Timothy J.
2015-07-30
MALEATE SALTS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-- DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE
App 20150203501 - WILKINSON; H. Scott ;   et al.
2015-07-23
Formulations, Salts And Polymorphs Of Transnorsertraline And Uses Thereof
App 20150196502 - LAUGHLIN; Sharon M. ;   et al.
2015-07-16
Methods and Compositions For Treating Sleep-Related Breathing Disorders
App 20150196531 - Handley; Dean A. ;   et al.
2015-07-16
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Grant 9,072,699 - Jerussi , et al. July 7, 2
2015-07-07
Methods of using derivatives of (-)-venlafaxine
Grant 9,072,700 - Jerussi , et al. July 7, 2
2015-07-07
Heteroaryl Compounds and Methods of Use Thereof
App 20150166571 - Campbell; John Emmerson ;   et al.
2015-06-18
Pyrrolidine triple reuptake inhibitors
Grant 9,056,830 - Shao , et al. June 16, 2
2015-06-16
Acetamide stereoisomer
Grant 9,040,588 - Abolin , et al. May 26, 2
2015-05-26
Cycloalkylamines As Monoamine Reuptake Inhibitors
App 20150126511 - SHAO; Liming ;   et al.
2015-05-07
Heteroaryl Compounds And Methods Of Use Thereof
App 20150072974 - Jones; Phillip G. ;   et al.
2015-03-12
Levalbuterol Salt
App 20150071969 - MCGLYNN; Paul ;   et al.
2015-03-12
Substituted quinoxalines and quinoxalinones as PDE-10 inhibitors
Grant 8,969,349 - Campbell , et al. March 3, 2
2015-03-03
Formulations, salts and polymorphs of transnorsertraline and uses thereof
Grant 8,957,114 - Laughlin , et al. February 17, 2
2015-02-17
Heteroaryl Compounds and Methods of Use Thereof
App 20150031709 - Campbell; John Emmerson ;   et al.
2015-01-29
Compounds For Treating Disorders Mediated By Metabotropic Glutamate Receptor 5, And Methods Of Use Thereof
App 20140349992 - Hardy; Larry Wendell ;   et al.
2014-11-27
Method for treating a sleep disorder with eszopiclone maleate
Grant 8,889,685 - Wilkinson , et al. November 18, 2
2014-11-18
Method of decreasing the bitterness of a pharmaceutical dosage form containing zopiclone
Grant 8,889,686 - Wilkinson , et al. November 18, 2
2014-11-18
Arformoterol And Tiotropium Compositions And Methods For Use
App 20140336218 - HUANG; Holly ;   et al.
2014-11-13
Dopamine-agonist combination therapy for improving sleep quality
Grant 8,877,755 - Barberich November 4, 2
2014-11-04
Cycloalkylamines as monoamine reuptake inhibitors
Grant 8,877,975 - Shao , et al. November 4, 2
2014-11-04
Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders
App 20140315910 - Caron; Judy ;   et al.
2014-10-23
Heteroaryl Compounds And Methods Of Use Thereof
App 20140288062 - Campbell; John Emmerson ;   et al.
2014-09-25
Coated Tablets Of Eszopiclone
App 20140271858 - HSIA; Richard ;   et al.
2014-09-18
Multicyclic Compounds and Methods of Use Thereof
App 20140256712 - SHAO; Liming ;   et al.
2014-09-11
Method for treating anxiety with a dosage form of besylate salts of zopiclone or eszopiclone
Grant 8,809,332 - Hsia , et al. August 19, 2
2014-08-19
Metabotrophic Glutamate Receptor 5 Modulators And Methods Of Use Thereof
App 20140221332 - Heffernan; Michele L. R. ;   et al.
2014-08-07
Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
Grant 8,772,301 - Hardy , et al. July 8, 2
2014-07-08
[1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterases
Grant 8,765,760 - Campbell , et al. July 1, 2
2014-07-01
Levalbuterol salt
Grant 8,765,153 - McGlynn , et al. July 1, 2
2014-07-01
Metabotrophic Glutamate Receptor 5 Modulators And Methods Of Use Thereof
App 20140179682 - Heffernan; Michele L. R. ;   et al.
2014-06-26
Pyrrolidine triple reuptake inhibitors
Grant 8,754,117 - Shao , et al. June 17, 2
2014-06-17
Acetamide Stereoisomer
App 20140135300 - Abolin; Craig R. ;   et al.
2014-05-15
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE
App 20140128474 - JERUSSI; Thomas ;   et al.
2014-05-08
Methods Of Using Derivatives Of (-)-venlafaxine
App 20140121283 - JERUSSI; Thomas P. ;   et al.
2014-05-01
Phenyl Substituted Cycloalkylamines As Monoamine Reuptake Inhibitors
App 20140121282 - SHAO; Liming ;   et al.
2014-05-01
Carbonate and carbamate modified forms of glucocorticoids in combination with .beta..sub.2 adrenergic agonists
Grant 8,710,036 - Currie , et al. April 29, 2
2014-04-29
Multicyclic compounds and methods of use thereof
Grant 8,710,245 - Shao , et al. April 29, 2
2014-04-29
Triple Reuptake Inhibitors And Methods Of Their Use
App 20140107175 - SHAO; Liming ;   et al.
2014-04-17
Pyrrolidine Triple Reuptake Inhibitors
App 20140073682 - SHAO; Liming ;   et al.
2014-03-13
Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
Grant 8,669,291 - Shao , et al. March 11, 2
2014-03-11
Acetamide stereoisomer
Grant 8,664,441 - Abolin , et al. March 4, 2
2014-03-04
Preparation Of Chiral Amides And Amines
App 20140057990 - Zhao; Hang ;   et al.
2014-02-27
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Grant 8,658,700 - Jerussi , et al. February 25, 2
2014-02-25
Methods of using derivatives of (-)-venlafaxine
Grant 8,642,662 - Jerussi , et al. February 4, 2
2014-02-04
Triple reuptake inhibitors and methods of their use
Grant 8,592,608 - Shao , et al. November 26, 2
2013-11-26
L-malate Salts Of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- Dihydro-5h-pyrrolo[3,4-b]pyrazine
App 20130296565 - WILKINSON; H. Scott ;   et al.
2013-11-07
Acetamide Stereoisomer
App 20130296607 - Abolin; Craig R. ;   et al.
2013-11-07
Besylate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6,7-- dihydro-5H-Pyrrolo[3,4-b]Pyrazine
App 20130289039 - Hsia; Richard ;   et al.
2013-10-31
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
App 20130289013 - FANG; Qun Kevin ;   et al.
2013-10-31
MALEATE SALTS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-- DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE
App 20130289040 - WILKINSON; H. Scott ;   et al.
2013-10-31
Method for treating a sleep disorder with a dosage form of a zopiclone or eszopiclone L-malate salt
Grant 8,541,416 - Wilkinson , et al. September 24, 2
2013-09-24
Carbonate And Carbamate Modified Forms Of Glucocorticoids In Combination With B2 Adrenergic Agonists
App 20130244988 - CURRIE; Mark G. ;   et al.
2013-09-19
Levalbuterol Salt
App 20130236515 - MCGLYNN; Paul ;   et al.
2013-09-12
Preparation of chiral amides and amines
Grant 8,524,950 - Zhao , et al. September 3, 2
2013-09-03
Acetamide stereoisomer
Grant 8,501,994 - Abolin , et al. August 6, 2
2013-08-06
Method for providing blood levels of eszopiclone with maleate salts
Grant 8,497,268 - Wilkinson , et al. July 30, 2
2013-07-30
Imidazo[1,2-a]pyridine compounds
Grant 8,497,278 - Fang , et al. July 30, 2
2013-07-30
Method for treating a sleep disorder with a dosage form of besylate salts of zopiclone or eszopiclone
Grant 8,497,267 - Hsia , et al. July 30, 2
2013-07-30
Treatment of CNS Disorders with trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
App 20130158125 - Jerussi; Thomas ;   et al.
2013-06-20
Heteroaryl Compounds And Methods Of Use Thereof
App 20130158003 - Campbell; John Emmerson ;   et al.
2013-06-20
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
Grant 8,445,470 - Currie , et al. May 21, 2
2013-05-21
Histamine H3 inverse agonists and antagonists and methods of use thereof
Grant 8,404,670 - Chytil , et al. March 26, 2
2013-03-26
Methods and compositions using racemic, (R)-, and (S)-fexofenadine in combination with leukotriene inhibitors
Grant 8,404,715 - Rubin March 26, 2
2013-03-26
Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders
App 20130065904 - CARON; Judy ;   et al.
2013-03-14
Pyrrolidine triple reuptake inhibitors
Grant 8,389,559 - Shao , et al. March 5, 2
2013-03-05
Levalbuterol Salt
App 20130028845 - McGlynn; Paul ;   et al.
2013-01-31
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Grant 8,344,030 - Jerussi , et al. January 1, 2
2013-01-01
Process for preparation of trans 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1Napthalenamine
Grant 8,329,950 - Caron , et al. December 11, 2
2012-12-11
MALEATE SALTS OF 6-(5-CHLORO-2-PYRIDYL)-5-[(4-METHYL-1-PIPERAZINYL)CARBONYLOXY]-7-OXO-6,7-- DIHYDRO-5H-PYRROLO[3,4-b]PYRAZINE
App 20120238580 - Wilkinson; H. Scott ;   et al.
2012-09-20
Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- dihydro-5H-pyrrolo[3,4-b]pyrazine
Grant 8,268,832 - Wilkinson , et al. September 18, 2
2012-09-18
L-malate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-Oxo-6,7-- dihydro-5H-pyrrolo[3,4-b]pyrazine
Grant 8,269,005 - Wilkinson , et al. September 18, 2
2012-09-18
L-malate Salts Of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- Dihydro-5h-pyrrolo[3,4-b]pyrazine
App 20120220597 - WILKINSON; H. Scott ;   et al.
2012-08-30
Besylate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4 Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6, 7-dihydro-5H-Pyrrolo[3,4-b]Pyrazine
App 20120220598 - HSIA; Richard ;   et al.
2012-08-30
Methods of treatment of chronic pain using eszopiclone
Grant 8,247,417 - Wessel , et al. August 21, 2
2012-08-21
Heteroaryl Compounds And Methods Of Use Thereof
App 20120178748 - CAMPBELL; John Emmerson ;   et al.
2012-07-12
Histamine H3 Inverse Agonists And Antagonists And Methods Of Use Thereof
App 20120172350 - Chytil; Milan ;   et al.
2012-07-05
Maleate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- dihydro-5H-pyrrolo[3,4-b]pyrazine
Grant 8,212,036 - Wilkinson , et al. July 3, 2
2012-07-03
L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- dihydro-5H-pyrrolo[3,4-b]pyrazine
Grant 8,198,277 - Wilkinson , et al. June 12, 2
2012-06-12
Besylate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-- dihydro-5H-pyrrolo[3,4-b]pyrazine
Grant 8,198,278 - Hsia , et al. June 12, 2
2012-06-12
Treatment of CNS Disorders with trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
App 20120136065 - JERUSSI; Thomas P. ;   et al.
2012-05-31
Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders
App 20120123164 - CARON; Judy ;   et al.
2012-05-17
Carbamate stereoisomer
Grant 8,173,829 - Abolin , et al. May 8, 2
2012-05-08
Formoterol Tartrate Process And Polymorph
App 20120108670 - TANOURY; Gerald J. ;   et al.
2012-05-03
Preparation Of Chiral Amides And Amines
App 20120095106 - ZHAO; Hang ;   et al.
2012-04-19
Compositions Comprising Transnorsertraline And Serotonin Receptor 1a Agonists/antagonists And Uses Thereof
App 20120077818 - Campbell; Una ;   et al.
2012-03-29
Histamine H3 Inverse Agonists And Antagonists And Methods Of Use Thereof
App 20120077802 - Chytil; Milan ;   et al.
2012-03-29
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
Grant 8,134,029 - Jerussi , et al. March 13, 2
2012-03-13
Methods Of Treatment Of Chronic Pain Using Eszopiclone
App 20120035182 - Wessel; Thomas ;   et al.
2012-02-09
Formoterol tartrate process and polymorph
Grant 8,110,706 - Tanoury , et al. February 7, 2
2012-02-07
Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
Grant 8,097,625 - Lalji , et al. January 17, 2
2012-01-17
Compounds for Treating Disorders Mediated by Metabotropic Glutamate Receptor 5, and Methods of Use Thereof
App 20110319380 - Hardy; Larry Wendell ;   et al.
2011-12-29
Methods of treatment of chronic pain using eszopiclone
Grant 8,071,599 - Wessel , et al. December 6, 2
2011-12-06
Histamine H3 inverse agonists and antagonists and methods of use thereof
Grant 8,063,032 - Chytil , et al. November 22, 2
2011-11-22
Arformoterol And Tiotropium Compositions And Methods For Use
App 20110250242 - Huang; Holly ;   et al.
2011-10-13
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
App 20110166146 - Fang; Qun Kevin ;   et al.
2011-07-07
Pyrrole And Pyrazole Daao Inhibitors
App 20110092559 - FANG; Q. Kevin ;   et al.
2011-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed